The Medical University of Silesia is a university located in Katowice, Poland. The university has 10,218 students and a teaching staff of 1201, including 295 professors. There are five faculties: Medicine, Dentistry, Pharmacy, Public Health, Health Sciences.

During the past decade, Medical University of Silesia conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 2 clinical trials were completed, i.e. on average, 6.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 1 clinical trials were completed. i.e. 7.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical University of Silesia" #1 sponsor was "Medical University of Silesia" with 19 trials, followed by "Medical University of Warsaw" with 3 trials sponsored, "Fresenius Kabi" with 2 trials sponsored, "University Hospital, Basel, Switzerland" with 2 trials sponsored and "medac GmbH" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical University of Silesia" #1 collaborator was "Silesian University of Medicine" with 6 trials as a collaborator, "Swiss National Science Foundation" with 2 trials as a collaborator, "B. Braun Melsungen AG" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Cardialysis BV" with 1 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Medical University of Silesia" are "Coronary Artery Disease" (3 trials), "Postoperative Nausea and Vomiting" (3 trials), "Postoperative Pain" (3 trials), "Temporomandibular Disorder" (3 trials) and "Vitreoretinal Surgeries" (3 trials). Many other conditions were trialed in "Medical University of Silesia" in a lesser frequency.

Most popular intervention types in "Medical University of Silesia" are "Drug" (16 trials), "Procedure" (14 trials), "Device" (9 trials), "Biological" (5 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Metamizol" (3 trials), "0,5 % bupivacaine with of 2% lidocaine" (2 trials), "Remifentanil" (2 trials), "Treosulfan" (2 trials) and "filgrastim" (2 trials). Other intervention names were less common.

The vast majority of trials in "Medical University of Silesia" are 43 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Medical University of Silesia". 2 are not yet recruiting, 12 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Medical University of Silesia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medical University of Silesia, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 20 trials that are defined as “Not Applicable".